And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

BCRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $31,920.00

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

^$4.21

▲ +0.05 (1.20%)

As of 04/26/2024 01:09 PM ET

Days: 30 | 90 | 365

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

BioCryst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/15/2023	Machelle Sanders	Director	Sell	4,000	$7.98	$31,920.00	25,611
2/1/2023	Jon P. Stonehouse	CEO	Sell	100,000	$10.38	$1,038,000.00	1,008,739
12/15/2022	Anthony Doyle	CFO	Sell	5,700	$10.90	$62,130.00	163,966
12/15/2022	Helen M Thackray	Insider	Sell	3,125	$10.89	$34,031.25	133,275
12/15/2022	Jon P. Stonehouse	CEO	Sell	14,100	$10.90	$153,690.00	887,730
12/15/2022	Michael L Jones	Director	Sell	445	$10.90	$4,850.50	10,753
12/2/2022	Jon P. Stonehouse	CEO	Sell	82,656	$12.80	$1,057,996.80	901,830
12/1/2022	Michael L Jones	Director	Sell	8,600	$13.01	$111,886.00	11,198
11/14/2022	Yarlagadda S. Babu	Insider	Sell	31,515	$13.88	$437,428.20	298,541
4/1/2022	Helen M Thackray	Insider	Sell	7,600	$16.20	$123,120.00	136,400
2/15/2022	George B. Abercrombie	Director	Sell	5,000	$18.50	$92,500.00
1/11/2022	Jon P. Stonehouse	CEO	Sell	184,000	$15.04	$2,767,360.00
12/7/2021	Yarlagadda S. Babu	Insider	Sell	30,100	$12.20	$367,220.00
11/24/2021	Vincent Milano	Director	Buy	7,500	$12.19	$91,425.00
11/23/2021	Anthony Doyle	CFO	Buy	35,258	$12.48	$440,019.84
11/15/2021	George B. Abercrombie	Director	Sell	5,000	$12.27	$61,350.00
10/15/2021	Nancy J. Hutson	Director	Sell	105,000	$15.40	$1,617,000.00
9/10/2021	George B. Abercrombie	Director	Sell	74,000	$15.09	$1,116,660.00
7/15/2021	George B. Abercrombie	Director	Sell	5,000	$15.69	$78,450.00	8,000
5/27/2021	William P. Sheridan	Insider	Sell	71,759	$15.00	$1,076,385.00	39,434
5/24/2021	George B. Abercrombie	Director	Sell	6,667	$13.90	$92,671.30	9,667
5/10/2021	George B. Abercrombie	Director	Sell	7,000	$12.70	$88,900.00	3,000

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	386,885	$1.97M	0.0%	-26.9%	0.188%
4/23/2024	Rice Hall James & Associates LLC	2,151,545	$10.93M	0.6%	-2.1%	1.044%
4/5/2024	Los Angeles Capital Management LLC	89,614	$0.46M	0.0%	+68.0%	0.043%
3/11/2024	Vanguard Group Inc.	17,763,720	$106.41M	0.0%	+15.4%	8.617%
3/5/2024	Fisher Asset Management LLC	2,884,569	$17.28M	0.0%	-9.4%	1.399%
2/27/2024	Counterweight Ventures LLC	13,500	$81K	0.1%	N/A	0.007%
2/20/2024	Quarry LP	9,000	$54K	0.0%	N/A	0.004%
2/14/2024	Oracle Investment Management Inc.	535,558	$3.21M	2.0%	-3.6%	0.261%
2/14/2024	Braidwell LP	5,718,477	$34.25M	1.3%	+6.6%	2.792%
2/14/2024	Avoro Capital Advisors LLC	13,050,000	$78.17M	1.1%	+13.0%	6.372%
2/14/2024	Kynam Capital Management LP	4,600,000	$27.55M	3.1%	+46.8%	2.246%
2/13/2024	Tower Research Capital LLC TRC	10,420	$62K	0.0%	+131.1%	0.005%
2/13/2024	Rafferty Asset Management LLC	955,587	$5.72M	0.0%	+18.3%	0.467%
2/12/2024	Capstone Investment Advisors LLC	18,650	$0.11M	0.0%	N/A	0.009%
2/9/2024	Aigen Investment Management LP	12,670	$76K	0.0%	-91.7%	0.006%
2/9/2024	GW&K Investment Management LLC	2,337,683	$14M	0.1%	-9.1%	1.141%
2/9/2024	Trexquant Investment LP	421,516	$2.53M	0.1%	-28.9%	0.206%
2/9/2024	Norges Bank	2,216,612	$13.28M	0.0%	N/A	1.082%
2/8/2024	Panagora Asset Management Inc.	669,067	$4.01M	0.0%	-8.0%	0.327%
2/8/2024	Pinnacle Wealth Planning Services Inc.	20,561	$0.12M	0.0%	N/A	0.010%
2/7/2024	Jump Financial LLC	128,771	$0.77M	0.0%	-68.2%	0.063%
2/7/2024	BNP Paribas Financial Markets	790,163	$4.73M	0.0%	+45.5%	0.386%
2/7/2024	Teacher Retirement System of Texas	43,827	$0.26M	0.0%	-18.3%	0.021%
2/7/2024	E Fund Management Co. Ltd.	51,317	$0.31M	0.0%	+23.7%	0.025%
2/6/2024	Charles Schwab Investment Management Inc.	1,594,436	$9.55M	0.0%	+9.1%	0.778%
2/6/2024	Amalgamated Bank	24,257	$0.15M	0.0%	-7.2%	0.012%
2/6/2024	Los Angeles Capital Management LLC	53,330	$0.32M	0.0%	+61.0%	0.026%
2/6/2024	Swiss National Bank	373,468	$2.24M	0.0%	-10.1%	0.182%
2/6/2024	Fisher Asset Management LLC	2,884,097	$17.28M	0.0%	-9.5%	1.408%
2/5/2024	Victory Capital Management Inc.	26,842	$0.16M	0.0%	+31.5%	0.013%
2/1/2024	New York State Common Retirement Fund	59,075	$0.35M	0.0%	-23.2%	0.029%
2/1/2024	Handelsbanken Fonder AB	45,900	$0.28M	0.0%	+29.3%	0.022%
1/31/2024	abrdn plc	504,528	$3.02M	0.0%	N/A	0.246%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	47,359	$0.28M	0.0%	+27.1%	0.023%
1/30/2024	Mackenzie Financial Corp	23,439	$0.14M	0.0%	+74.7%	0.011%
1/26/2024	Mutual of America Capital Management LLC	221,552	$1.33M	0.0%	-1.7%	0.108%
1/25/2024	MA Private Wealth	12,700	$76K	0.0%	N/A	0.006%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	122,180	$0.73M	0.0%	+6.3%	0.060%
1/24/2024	China Universal Asset Management Co. Ltd.	23,692	$0.14M	0.0%	+387.0%	0.012%
1/19/2024	JGP Global Gestao de Recursos Ltda.	10,650	$64K	0.1%	N/A	0.005%
1/17/2024	Assenagon Asset Management S.A.	529,419	$3.17M	0.0%	-52.3%	0.258%
1/12/2024	SG Americas Securities LLC	66,223	$0.40M	0.0%	N/A	0.032%
12/18/2023	Vanguard Group Inc.	15,392,319	$108.98M	0.0%	+2.0%	7.515%
11/17/2023	Jacobs Levy Equity Management Inc.	470,137	$3.33M	0.0%	-59.3%	0.230%
11/15/2023	GSA Capital Partners LLP	191,527	$1.36M	0.1%	+167.8%	0.094%
11/15/2023	Rock Springs Capital Management LP	2,551,226	$18.06M	0.5%	+2.2%	1.246%
11/15/2023	Kynam Capital Management LP	3,133,193	$22.18M	3.6%	+10.0%	1.530%
11/15/2023	ELCO Management Co. LLC	31,811	$0.23M	0.2%	+134.9%	0.016%
11/15/2023	AXQ Capital LP	23,134	$0.16M	0.1%	+31.9%	0.011%
11/14/2023	Braidwell LP	5,362,980	$37.97M	1.2%	+92.1%	2.619%
11/14/2023	Gotham Asset Management LLC	69,033	$0.49M	0.0%	N/A	0.034%
11/14/2023	Deerfield Management Company L.P. Series C	3,286,000	$23.27M	0.5%	+148.6%	1.604%
11/14/2023	Teza Capital Management LLC	36,904	$0.26M	0.0%	+12.8%	0.018%
11/14/2023	Trexquant Investment LP	592,612	$4.20M	0.1%	+76.6%	0.289%
11/14/2023	Profund Advisors LLC	136,652	$0.97M	0.1%	-22.7%	0.067%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	542,776	$3.84M	0.0%	+35.3%	0.265%
11/13/2023	Algert Global LLC	207,095	$1.47M	0.1%	-29.0%	0.101%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	384,000	$2.72M	0.0%	N/A	0.187%
11/13/2023	Visionary Wealth Advisors	33,540	$0.24M	0.0%	-13.0%	0.016%
11/13/2023	Silverarc Capital Management LLC	791,671	$5.61M	1.7%	+4.0%	0.387%
11/13/2023	Aigen Investment Management LP	153,474	$1.09M	0.2%	+96.0%	0.075%
11/13/2023	FMR LLC	2,953,373	$20.91M	0.0%	+0.1%	1.442%
11/13/2023	Rafferty Asset Management LLC	807,888	$5.72M	0.0%	-17.1%	0.394%
11/13/2023	Kestra Advisory Services LLC	18,779	$0.13M	0.0%	-28.0%	0.009%
11/13/2023	PNC Financial Services Group Inc.	11,917	$84K	0.0%	-33.6%	0.006%
11/13/2023	E Fund Management Co. Ltd.	41,497	$0.29M	0.0%	-20.8%	0.020%
11/9/2023	Rhumbline Advisers	295,335	$2.09M	0.0%	-5.9%	0.156%
11/9/2023	Deutsche Bank AG	99,711	$0.71M	0.0%	+11.8%	0.053%
11/9/2023	Mutual of America Capital Management LLC	225,323	$1.60M	0.0%	+2.5%	0.119%
11/9/2023	UBS Group AG	305,951	$2.17M	0.0%	-21.2%	0.161%
11/8/2023	Charles Schwab Investment Management Inc.	1,460,807	$10.34M	0.0%	+1.3%	0.771%
11/8/2023	Swiss National Bank	415,368	$2.94M	0.0%	+1.2%	0.219%
11/7/2023	Virtus ETF Advisers LLC	38,321	$0.27M	0.2%	-11.5%	0.020%
11/7/2023	Quantbot Technologies LP	64,100	$0.45M	0.0%	N/A	0.034%
11/7/2023	New York State Common Retirement Fund	76,896	$0.54M	0.0%	+23.2%	0.041%
11/7/2023	Barclays PLC	547,328	$3.88M	0.0%	-0.4%	0.289%
11/7/2023	Fox Run Management L.L.C.	25,476	$0.18M	0.1%	N/A	0.013%
11/7/2023	Jump Financial LLC	404,913	$2.87M	0.1%	+371.5%	0.214%
11/7/2023	Great Valley Advisor Group Inc.	16,300	$0.12M	0.0%	+34.7%	0.009%
11/6/2023	Assenagon Asset Management S.A.	1,109,904	$7.86M	0.0%	-79.2%	0.586%
11/2/2023	Rice Hall James & Associates LLC	2,275,638	$16.11M	1.0%	+21.5%	1.201%
10/31/2023	Teacher Retirement System of Texas	53,640	$0.38M	0.0%	+4.9%	0.028%
10/31/2023	Panagora Asset Management Inc.	727,480	$5.15M	0.0%	+6.1%	0.384%
10/31/2023	Fifth Third Bancorp	3,520	$25K	0.0%	+17,500.0%	0.002%
10/31/2023	China Universal Asset Management Co. Ltd.	4,865	$34K	0.0%	+96.4%	0.003%
10/30/2023	Arete Wealth Advisors LLC	23,300	$0.17M	0.0%	+64.7%	0.012%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	114,960	$0.81M	0.0%	-5.9%	0.061%
10/25/2023	Mackenzie Financial Corp	13,413	$95K	0.0%	-74.2%	0.007%
10/24/2023	Bank of New York Mellon Corp	767,571	$5.43M	0.0%	+1.1%	0.405%
10/24/2023	J.W. Cole Advisors Inc.	19,900	$0.14M	0.0%	-10.4%	0.011%
10/16/2023	Bender Robert & Associates	56,600	$0.40M	0.1%	-17.5%	0.030%
10/12/2023	Moody National Bank Trust Division	52,046	$0.37M	0.0%	+22.5%	0.027%
10/12/2023	Legato Capital Management LLC	23,225	$0.16M	0.0%	N/A	0.012%
10/10/2023	Franklin Street Advisors Inc. NC	60,000	$0.43M	0.0%	+20.0%	0.032%
8/15/2023	Silverarc Capital Management LLC	760,904	$5.36M	1.7%	+31.7%	0.402%
8/15/2023	Kynam Capital Management LP	2,848,197	$20.05M	2.8%	+184.8%	1.503%
8/15/2023	Braidwell LP	2,791,880	$19.66M	0.6%	+43.5%	1.473%
8/14/2023	PDT Partners LLC	199,079	$1.40M	0.2%	+80.2%	0.105%
8/14/2023	Bison Wealth LLC	151,015	$1.06M	0.2%	N/A	0.080%
8/14/2023	Rock Springs Capital Management LP	2,497,193	$17.58M	0.4%	+7.0%	1.318%

Data available starting January 2016

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Today's Range

Now: $4.21

$4.11

$4.26

50 Day Range

MA: $5.13

$4.21

$5.92

52 Week Range

Now: $4.21

$4.03

$9.06

Volume

662,544 shs

Average Volume

3,278,639 shs

Market Capitalization

$867.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top insider shareholders include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Anthony Doyle (CFO)
Helen M Thackray (Insider)
Machelle Sanders (Director)
Michael L Jones (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.
Who are the major institutional investors of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top institutional shareholders include:
Rice Hall James & Associates LLC — 1.04%
Assenagon Asset Management S.A. — 0.19%
Los Angeles Capital Management LLC — 0.04%
Simplex Trading LLC — 0.00%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.
Which major investors are selling BioCryst Pharmaceuticals stock?: During the last quarter, BCRX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Rice Hall James & Associates LLC
Which major investors are buying BioCryst Pharmaceuticals stock?: In the last quarter, BCRX stock was acquired by institutional investors including:
Simplex Trading LLC
Los Angeles Capital Management LLC

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here